SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000884731-16-000114
Filing Date
2016-11-08
Accepted
2016-11-08 17:32:16
Documents
78
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q Q3 2016 FILING a2016q310-q.htm 10-Q 1068845
2 EXHIBIT 10.1 v450376_ex10-1.htm EX-10.1 107196
3 EXHIBIT 31.1 a2016q2exhibit3111.htm EX-31.1 13881
4 EXHIBIT 31.2 a2016q2exhibit3121.htm EX-31.2 13868
5 EXHIBIT 32.1 a2016q2exhibit3211.htm EX-32.1 12123
  Complete submission text file 0000884731-16-000114.txt   6870016

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT aria-20160930.xml EX-101.INS 1302084
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT aria-20160930.xsd EX-101.SCH 59187
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT aria-20160930_cal.xml EX-101.CAL 82936
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT aria-20160930_def.xml EX-101.DEF 299478
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT aria-20160930_lab.xml EX-101.LAB 775517
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT aria-20160930_pre.xml EX-101.PRE 457370
Mailing Address 26 LANDSDOWNE CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE ST CAMBRIDGE MA 02139 6174940400
ARIAD PHARMACEUTICALS INC (Filer) CIK: 0000884731 (see all company filings)

IRS No.: 223106987 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36172 | Film No.: 161982203
SIC: 2836 Biological Products, (No Diagnostic Substances)